LGWWJX protects obesity-related asthma through mechanisms including the inhibition of the IL-1β/ILC3/IL-17A/AHR axis, anti-inflammatory effects, weight loss, and the regulation of lipid metabolism. Here, IL1B is linked to obesity due to melanocortin 4 receptor deficiency.